[1] 吴强强.格林巴利综合征相关研究近况[J].实用医药杂志, 2010, 27(7):651-653. [2] Haber P, Sejvar J, Mikaeloff Y, et al.Vaccines and Guillain-Barré Syndrome[J].Drug Saf, 2009, 32 (4): 309-323. [3] Israeli E,Agmon-Levin N,Blank M,et al. Guillain Barré Syndrome-A Classical Autoimmune Disease Triggered by Infection or Vaccination[J].Clinic Rev Allerg Immunol,2010 Oct 5.[Epub ahead of print]. [4] 王殿华. 格林巴利综合征的病因及发病机制[J].中国社区医师, 2010, 38:4. [5] Black S, Eskola J, Siegrist C-A, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines[J].Lancet, 2009, 374(9707): 2115-2122. [6] Richard A, Hughes FRCP, Judith Charlton MS, et al. No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000[J].Arch Intern Med.2006,166(12):1301-1304. [7] Landaverde JM, Danovaro-Holliday MC, Trumbo SP, et al. Guillain-Barré Syndrome in Children Aged <15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic[J].J Infect Dis, 2010, 201(5):746-750. [8] Guillain-Barré syndrome among recipients of Menactra meningo-coccal conjugate vaccine-United States, June-July 2005[J]. MMWR Morb Mortal Wkly Rep, 2005 Oct 14,54(40):1023-1025. [9] Preliminary Results: Surveillance for Guillain-Barré Syndrome After Receipt of Influenza A(H1N1) 2009 Monovalent Vaccine- United States, 2009-2010[J].MMWR Morb Mortal Wkly Rep, 2010 Jun 4,59(21):657-661. [10] Liang XF, Li L, Liu DW, et al. safety of influenza A (H1N1) vaccine in postmarketing surveillance in china[J].N Engl J Med, 2011,364(7):638-647. [11] Burwen DR, Ball R, Bryan WW, et al. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001[J]. Am J Prev Med, 2010,39(4):296-304. [12] Kobayashi M, Takechi M, Kondo K, et al. Literature review on the association between inactivated influenza vaccines and the Guillain-Barré syndrome[J].Nippon Koshu Eisei Zasshi,2010,57(8):605-611. [13] Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June 2005-September 2006[J].MMWR Morb Mortal Wkly Rep,2006,55(41):1120-1124. [14] Wals PD, Deceuninck G, Boucher RM, et al. Risk of Guillain-Barré Syndrome following Serogroup C Meningococcal Conjugate Vaccine in Quebec, Canada[J].Clin Infect Dis, 2008 ,46(8):75-77. [15] Souayah N, Michas-Martin PA, Nasar A, et al. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009[J].Vaccine, 2011,29(5):886-889. (因版面有限,部分参考文献省略,如有需要,请联系编辑部) |